Patent ID: 11897924
Assignee: BIOXODES
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 3:
4. A pharmaceutical composition or a medicament comprising a fusion protein comprising (i) at least one Ixodes ricinus salivary gland (IrCPI) polypeptide, having an amino sequence at least 95% identical to SEQ ID NO: 1, (ii) at least one human serum albumin polypeptide and (iii) at least one peptide linker, wherein the fusion protein has an increased circulatory half-life compared to an unfused IrCPI polypeptide, and at least one pharmaceutically acceptable excipient, wherein said at least one peptide linker is a Pro-rich linker selected from a group consisting of (AP)n and P(AP)n linker, and wherein “n” is a number from 5 to 15.